Researchers at the Johns Hopkins Bloomberg—Kimmel Institute for Cancer Immunotherapy developed a new way to use bioinformatics as a gathering tool to determine how a patient’s immune system responds to immunotherapy and recognizes its own tumor.
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
